Low-Dose Intra-Arterial Urokinase and Aggressive Mechanical Clot Disruption for Acute Ischemic Stroke after Failure of Intravenous Thrombolysis

References

1. 1.↵
   1. del Zoppo GJ,
   2. Poeck K,
   3. Pessin MS,
   4. et al

   . Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78–86

   CrossRefPubMedWeb of Science
2. 2.↵
   1. von Kummer R,
   2. Hacke W

   . Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992; 23: 646–52

   Abstract/FREE Full Text
3. 3.↵
   1. Lee KY,
   2. Han SW,
   3. Kim SH,
   4. et al

   . Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 2007; 38: 192–93

   Abstract/FREE Full Text
4. 4.↵
   The IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke 2004; 35: 904–12

   Abstract/FREE Full Text
5. 5.↵
   The IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke 2007; 38: 2127–35

   Abstract/FREE Full Text
6. 6.↵
   1. Lee KY,
   2. Kim DI,
   3. Kim SH,
   4. et al

   . Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004; 25: 1470–75

   Abstract/FREE Full Text
7. 7.↵
   1. Kim DJ,
   2. Kim DI,
   3. Kim SH,
   4. et al

   . Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 2005; 47: 616–21

   CrossRefPubMed
8. 8.↵
   1. Shaltoni HM,
   2. Albright KC,
   3. Gonzales NR,
   4. et al

   . Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007; 38: 80–84

   Abstract/FREE Full Text
9. 9.↵
   1. Vora NA,
   2. Gupta R,
   3. Thomas AJ,
   4. et al

   . Factors predicting hemorrhagic complications after multimodal reperfusion therapy for acute ischemic stroke. AJNR Am J Neuroradiol 2007; 28: 1391–94

   Abstract/FREE Full Text
10. 10.↵
    1. Brekenfeld C,
    2. Remonda L,
    3. Nedeltchev K,
    4. et al

    . Symptomatic intracranial hemorrhage after intra-arterial thrombolysis in acute ischemic stroke: assessment of 294 patients treated with urokinase. J Neurol Neurosurg Psychiatry 2007; 78: 280–85

    Abstract/FREE Full Text
11. 11.↵
    1. Khatri P,
    2. Wechsler LR,
    3. Broderick JP

    . Intracranial hemorrhage associated with revascularization therapies. Stroke 2007; 38: 431–40

    Abstract/FREE Full Text
12. 12.↵
    1. Qureshi AI,
    2. Siddiqui AM,
    3. Suri MF,
    4. et al

    . Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002; 51: 1319–29

    PubMedWeb of Science
13. 13.↵
    1. Sorimachi T,
    2. Fujii Y,
    3. Tsuchiya N,
    4. et al

    . Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol 2004; 25: 1391–402

    Abstract/FREE Full Text
14. 14.↵
    1. Noser EA,
    2. Shaltoni HM,
    3. Hall CE,
    4. et al

    . Aggressive mechanical clot disruption. A safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005; 36: 292–96

    Abstract/FREE Full Text
15. 15.↵
    The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–87

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Yoon W,
    2. Seo JJ,
    3. Cho KH,
    4. et al

    . Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology 2005; 237: 620–26

    PubMedWeb of Science
17. 17.↵
    1. Labiche LA,
    2. Al-Senani F,
    3. Wojner AW,
    4. et al

    . Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003; 34: 695–98

    Abstract/FREE Full Text
18. 18.↵
    1. Alexandrov AV,
    2. Burgin WS,
    3. Demchuk AM,
    4. et al

    . Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001; 103: 2897–902

    Abstract/FREE Full Text
19. 19.↵
    1. Mandava P,
    2. Kent TA

    . Intra-arterial therapies for acute ischemic stroke. Neurology 2007; 68: 2132–39

    Abstract/FREE Full Text
20. 20.↵
    1. Nakano S,
    2. Iseda T,
    3. Yoneyama T,
    4. et al

    . Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion. An alternative option to intra-arterial thrombolysis. Stroke 2002; 33: 2872–76

    Abstract/FREE Full Text
21. 21.↵
    1. Ikushima I,
    2. Ohta H,
    3. Hirai T,
    4. et al

    . Balloon catheter disruption of middle cerebral artery thrombus in conjunction with thrombolysis for the treatment of acute middle cerebral artery embolism. AJNR Am J Neuroradiol 2007; 28: 513–17

    Abstract/FREE Full Text